about
Circulating angiopoietin-2 is a marker for early cardiovascular disease in children on chronic dialysisThe virtues of vitamin D--but how much is too much?Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T.Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification.HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotypeHNF1B mutations associate with hypomagnesemia and renal magnesium wasting.Markers of bone metabolism are affected by renal function and growth hormone therapy in children with chronic kidney disease.Mineral metabolism in European children living with a renal transplant: a European society for paediatric nephrology/european renal association-European dialysis and transplant association registry studyThe post-transplant lymphoproliferative disorder-a literature review.The demise of calcium-based phosphate binders-is this appropriate for children?Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD.ADCK4-Associated Glomerulopathy Causes Adolescence-Onset FSGSAngioplasty for renovascular hypertension in children: 20-year experience.A bimodal association of vitamin D levels and vascular disease in children on dialysisThe vascular biology of calcification.Renal transplantation or bladder augmentation first? A comparison of complications and outcomes in children.Long-term outcome of chronic dialysis in children.Genetic, Environmental, and Disease-Associated Correlates of Vitamin D Status in Children with CKD.A dedicated vascular access clinic for children on haemodialysis: Two years' experience.Phosphate binders in CKD: chalking out the differences.Uraemic vasculopathy in children with chronic kidney disease: prevention or damage limitation?Dysregulated mineral metabolism in children with chronic kidney disease.Cardiovascular complications in children with chronic kidney disease.Can vitamin D slow down the progression of chronic kidney disease?Renal complications following lung and heart-lung transplantation.Mechanistic insights into vascular calcification in CKD.Phosphate is a vascular toxin.Nephrectomy for the failed renal allograft in children: predictors and outcomes.Encapsulating peritoneal sclerosis in children.Pleuro-peritoneal or pericardio-peritoneal leak in children on chronic peritoneal dialysis-A survey from the European Paediatric Dialysis Working Group.Kidney disease in children: latest advances and remaining challenges.Increasing sodium removal on peritoneal dialysis: applying dialysis mechanics to the peritoneal dialysis prescription.Cardiovascular Phenotypes in Children with CKD: The 4C Study.Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters.A phase I trial of epstein-barr virus gp350 vaccine for children with chronic kidney disease awaiting transplantation.Hemodialysis in children with ventriculoperitoneal shunts: prevalence, management and outcomes.The vascular phenotype of children with systemic lupus erythematosus.BMP-9 regulates the osteoblastic differentiation and calcification of vascular smooth muscle cells through an ALK1 mediated pathway.Successful outcome of renal transplantation in a child with HIV-associated nephropathy.Question 3: Is ultrasonography required to rule out congenital anomalies of the kidneys and urinary tract in babies with isolated preauricular tags or sinuses?
P50
Q21559692-62AE180E-60D8-4582-AACE-669CDFF15664Q30388106-A2E6AB8E-4E31-4C6A-83E5-4FA933AA8DD4Q33387252-5AD0AF33-BE6D-4C4A-B040-B3745B05D3CEQ33562186-0E58115B-F43C-477A-8040-2A8D48301204Q34427695-1325E945-4A24-4580-956C-D7849737116CQ34658412-6D712B92-2CA3-4157-92C2-82F68997E4A2Q35058295-9D46D232-C53F-4C1B-A23D-308062B88879Q35576091-5559B5D6-A2FA-4707-B0E1-90F64A6B77BDQ35676353-133DF261-6566-4563-BB3C-5E88A82FF8BAQ36214854-DA550512-4761-42EA-9545-06F805DA23CCQ36417881-2B8A8CBC-7681-4567-B5E6-06CBC8B3E534Q36417922-3362BD35-A056-4D31-A5BB-8A03898CB6F6Q36526499-A06AF65B-CF86-4E43-BD71-267D987BAB97Q36677652-820AE37E-9DAF-42A2-9ADA-0664CAD6ADCBQ36764999-5D73B1C4-162B-4F38-862E-6254F2BFE07BQ36990742-CE00C118-F5DF-4775-93E2-CDEB6FDD0BCBQ37063372-0388145F-3BD3-47B2-AF69-46537188F777Q37069988-B2531AEA-19BC-4BF7-B76C-AF27F940D1D3Q37427430-1398A7C4-9765-49E8-90D2-562057E14D2CQ37629694-79C094A5-8003-4B40-A0CE-2C8534C3D845Q37809763-0862B281-354F-4451-8D75-B3B037D6BE12Q37855479-30F7D9E8-79DF-4F1E-B437-9702D89B4283Q37930975-A9A3DA3F-BACF-4F86-B81B-FAF27AF6767FQ37967396-93584C2F-3B3B-40D7-B9F6-7192F739F881Q38021674-5309B857-99D6-4382-A0FE-4F6CCD7D1BC0Q38058699-E14F4259-4611-4EA0-AD31-E424CBE5FA23Q38060627-B3F00071-CB38-438A-8531-186C988AF138Q38100687-CCEFFB79-B330-4105-A1B1-503E95FA270CQ38164559-124CF914-6CC7-4ACD-9506-A55D5830ABBEQ38520888-970D1D73-D14A-421B-BB97-BDBDEC3E8364Q38718548-1A0561CA-3A65-4868-AFA8-6EC2FEEF206CQ38753954-C30DC504-9C7C-4502-A757-20702B822532Q39202599-96D21BD3-342C-4EF6-B8A8-65C0AF50FCF1Q39395889-05454663-BADB-4C66-845D-DE4561C9EFC8Q39935717-D3236BFA-41DB-4313-A62F-70C5B10BA395Q40522420-93CF1DF2-3C3F-42EA-B5F6-E2EEE3B19A31Q40910621-748A4310-BB44-4B6C-AD73-E830BAF1D89CQ41781589-2BD7CFFA-F926-4F85-868A-4D7BC18F43C1Q42199953-D3CD4FF1-5F64-4970-AF96-59AFED5B2A47Q42282040-5B9033A4-6BE2-4210-8994-0F094AED158E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rukshana Shroff
@ast
Rukshana Shroff
@en
Rukshana Shroff
@es
Rukshana Shroff
@nl
Rukshana Shroff
@sl
type
label
Rukshana Shroff
@ast
Rukshana Shroff
@en
Rukshana Shroff
@es
Rukshana Shroff
@nl
Rukshana Shroff
@sl
altLabel
R C Shroff
@en
prefLabel
Rukshana Shroff
@ast
Rukshana Shroff
@en
Rukshana Shroff
@es
Rukshana Shroff
@nl
Rukshana Shroff
@sl
P1053
C-7347-2008
P106
P31
P3829
P496
0000-0001-8501-1072
P569
2000-01-01T00:00:00Z